Insurers Must Cover Updated Cervical Cancer Screenings Free
Published Date: 1/5/2026
Notice
Summary
Starting soon, many health plans must cover updated cervical cancer screening tests for women without charging extra. These changes affect group and individual insurance plans and aim to keep women healthier by catching cancer early. The new rules come after expert reviews and public feedback, so expect smoother, no-cost screenings that save lives and money.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
No-Copay Coverage Required for Updated Screenings
Non-grandfathered group health plans and health insurance issuers offering group or individual coverage must cover, without cost-sharing, the services and screenings listed in the updated Women's Preventive Services Guidelines. The HRSA Administrator accepted the update on December 29, 2025, and plans with plan or policy years that begin 1 year after that date (for most plans, in 2027) must provide the coverage.
At-Home HPV Self-Collection Covered Option
The updated Guideline states that patient-collected high-risk human papillomavirus (hrHPV) testing is an appropriate method and should be offered as an option for cervical cancer screening in women aged 30 to 65 years at average risk. For covered plans, this option falls under the HRSA-supported Guidelines and must be included without cost-sharing beginning for plan years that start 1 year after acceptance (accepted Dec 29, 2025).
Changed Screening Methods and Intervals
The Guideline updates screening method and timing: women aged 21–29 should have cervical cytology (Pap test) every 3 years; women aged 30–65 should be screened with primary hrHPV testing every 5 years (preferred) or cytology plus hrHPV co-testing every 5 years; if hrHPV testing is unavailable, continue cytology alone every 3 years. These recommendations apply to average-risk women and are part of the services that covered plans must include without cost-sharing beginning for plan or policy years starting 1 year after acceptance (accepted Dec 29, 2025).
Follow-Up and Additional Tests Covered
The updated Guideline adds that additional testing and pathologic evaluation (for example, cytology, biopsy, colposcopy, extended genotyping, dual stain) may be required to complete the screening process and are recommended to complete screening for malignancies. For non-grandfathered plans, these services are part of the Guideline-covered preventive services and must be covered without cost-sharing for plan or policy years beginning 1 year after acceptance (accepted Dec 29, 2025).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12321 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Questionnaire and Data Collection Testing, Evaluation, and Research for the Health Resources and Services Administration, OMB No. 0915-0379-Revision
HRSA wants your thoughts on their plan to test and improve health questionnaires and surveys. This helps make sure their questions are clear and useful before they officially use them. If you have ideas or concerns, speak up by August 17, 2026—your feedback shapes better health data without costing extra money or time for most folks.
2026-12046 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Health Resources and Services Administration Uniform Data System
HRSA is asking for public feedback on updates to its Uniform Data System, which helps track how health centers serve over 32 million people across the U.S. and territories. This update affects health centers and similar groups that report data yearly, with a comment deadline of July 16, 2026. No big cost changes are expected, but your input helps keep health care reporting clear and useful!
2026-11989 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW
HRSA is rolling out a new 340B Rebate Model Pilot Program that changes how drug manufacturers offer discounts to certain health care providers. This means drug companies will submit plans and sales data, while health providers will request rebates differently. If you’re involved in the 340B program, get ready to share info and comment by July 15, 2026—this could impact how discounts and rebates flow, but no new costs are expected.
2026-11972 — National Vaccine Injury Compensation Program; List of Petitions Received
The National Vaccine Injury Compensation Program helps people who believe they were hurt by certain vaccines get money without a long court fight. HRSA just shared a list of new petitions filed, which means folks are asking for compensation now. If you or someone you know is affected, keep an eye on deadlines and possible payouts coming from these claims.
2026-11828 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Delta States Rural Development Network Grant Program, OMB No. 0915-0386-Revision
HRSA is updating how it collects info from groups getting grants to fight heart disease, diabetes, stroke, and obesity in rural Delta communities. They want your thoughts by July 13, 2026, before finalizing these changes. This helps make sure the program stays effective, easy to track, and ready to grow without extra costs.
2026-10850 — Notice of Supplemental Funding for the Black Lung Data and Resource Center
The Health Resources and Services Administration is giving an extra $50,000 to the University of Illinois, Chicago to help the Black Lung Data and Resource Center improve how they collect and analyze patient data. This funding runs from July 1, 2026, to June 30, 2027, and will boost clinic operations and services for people affected by black lung disease. It’s a one-time award to make sure clinics get better support and care.
Previous / Next Documents
Previous: 2025-24234 — Roster of Arbitrators-Annual Update
The Surface Transportation Board is updating its list of arbitrators who help settle rail-related disputes. Current arbitrators must confirm they want to stay on the list and update their info, while new folks with rail and dispute experience can apply by January 29, 2026. This update keeps the roster fresh and ready, with no direct cost changes but important for anyone involved in rail arbitration.
Next: 2025-24236 — Taking and Importing Marine Mammals; Taking Marine Mammals Incidental to Geophysical Surveys Related to Oil and Gas Activities in the Gulf of America (Formerly Gulf of Mexico)
NOAA just updated the rules for WesternGeco’s oil and gas surveys in the Gulf of America, letting them accidentally disturb a few marine mammals—but only in a way that won’t harm the population. This new permission lasts until April 19, 2026, keeping the balance between energy exploration and protecting sea life. If you’re curious, all the details and documents are online for anyone to check out!